Supportive effects of moderate physical exercise during cytotoxic/endocrine treatment of breast cancer patients - Results of a pilot study;Supportive effekte eines moderaten ausdauertrainings während der zytotoxischen/endokrinen therapie von mammakarzinompatientinnen - Ergebnisse einer pilotstudie

Geburtshilfe und Frauenheilkunde

Volumn 68, Issue 8, 2008, Pages 805-813

  Kohler N ^a   Damm, F ^b   Bauer, K ^b   Klee, C ^a   Rach, S ^b   Lintz, D ^a   Kaufmann, M ^a   Rody, Achim ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Landessportbund Hessen eV   (Germany)

Author keywords

Breast cancer; Physical exercise; Quality of life; Supportive therapy

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN; HORMONE;

ARTICLE; BODY WEIGHT; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; FATIGUE; FEMALE; HUMAN; MENTAL HEALTH; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; PILOT STUDY; QUALITY OF LIFE; SHORT FORM 36; UNSPECIFIED SIDE EFFECT; WELLBEING;

EID: 51549088163     PISSN: 00165751     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1038853     Document Type: Article

References (26)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Annals of Oncology 2007; 18: 581-592
2. Tyczynski JE, Plesko I, Aareleid T et al. Breast cancer mortality patterns and time trends in 10 new EU member states: mortality declining in young women, but still increasing in the elderly. Int J Cancer 2004; 112: 1056-1064
3. Kaufmann M, Beckmann MW, Emons G, Dall P, Ebert AD, Hantschmann P, von Minkwitz G, Schmalfeldt B, Hrsg. Aktuelle Empfehlungen der Arbeitsgemeinschaft Gynäkologische Onkologie. State of the Art 2006. München: W. Zuckschwerdt Verlag; 2006
4. Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. N Engl J Med 2001; 344: 1997-2008
5. Ganz PA, Kwan L, Stanton AL et al. Quality of life at the end of primary treatment of breast cancer: First results from the moving beyond cancer randomized trial. J Natl Cancer Inst 2004; 96: 376-387
6. Stefanek ME. Quality of life and other psychosocial issues in breast cancer. Curr Opin Oncol 1994; 6: 583-586
7. Ganz PA. Impact of tamoxifen adjuvant therapy on symptoms, functioning, and quality of life. J Natl Cancer Inst Monogr 2001; 30: 130-134
8. Ganz PA, Desmond KA, Leedham B et al. Quality of life in long term, disease-free survivors of breastcancer: A follow-up study. J Natl Cancer Inst 2002; 94: 39-49
9. Knols R, Aaronson NK, Uebelhart D et al. Physical exercise in cancer patients during and after medical treatment: A systematic review of randomized and controlled clinical trials. J Clin Oncol 2005; 23: 3830-3842
10. McNeely ML, Campbell KL, Rowe BH et al. A meta-analysis of exercise interventions in breast cancer patients and survivors. CMAJ 2006; 175: 34-41
11. Schmitz KH, Holtzman J, Courneya KS et al. Controlled physical activity trials in cancer survivors: A systematic review and meta-analysis. Cancer epidemiol Biomarkers Prev 2005; 14: 1588-1595
12. Courneya KS, Mackey JR, Bell GJ et al. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: Cardiopulmonary and quality of life outcomes. J Clin Oncol 2003; 21: 1660-1668
13. Dimeo FC. Effects of exercise on cancer-related fatigue. Cancer 2001; 92: 1689-1693
14. Kanter MM, Hamlin RL, Unverferth DV, Davis HW, Merola AJ. Effect of exercise training on antioxidant enzymes and cardiotoxicity of doxorubicin. J Appl Physiol 1985; 59: 1298-1303
15. Friedenreich CM, Thune I, Brinton LA, Albanes D. Epidemiologic issues related to the association between physical activity and breast cancer. Cancer 1998; 83: 600-610
16. Hoffmann-Goetz L, Apter D, Demark-Wahnefried W, Goran MI, McTtieman A, Reichman ME. Possible mechanisms mediating an assotiation between physical activity and breast cancer. Cancer 1998; 83: 621-628
17. McTiernan A. Exercise and breast cancer: Time to get moving? N Engl J Med 1997; 336: 1311-1312
18. Holmes MD, Chen WY, Feskanich D et al. Physical activity and survival after breast cancer diagnosis. JAMA 2005; 293: 2479-2486
19. Ware JE. SF-36 health survey. Boston, MA: New England Medical Center, The Health Institute, 1993
20. Cancer Therapy Evaluation Program, Common Terminology Criteria for Adverse Events, Version 3.0, DCTD, NCI, NIH, DHHS, March 31, 2003 (http://ctep.cancer.gov), Publish Date: August 9, 2006
21. Dimeo FC. Körperliche Aktivität und Krebs: Eine Übersicht. Deutsche Zeitschrift für Sportmedizin 2001; 52: 238-244
22. Rüffer U. Fatigue - Erschöpfung nach Tumortherapie. Psychoneuro 2004; 30: 218-220
23. MacVicar MG, Winningham ML, Nickel JL. Effect of aerobic intervall training on cancer patients' functional capacity. Nurs Res 1989; 38: 348-351
24. Winningham ML, MacVicar MG. The effect of aerobic exercise on patient reports on nausea. Oncol Nurs Forum 1988; 15: 447-450
25. Winningham ML, MacVicar MG, Bondac M, Anderson JI, Minton JP. Effect of aerobic exercise on body weight and composition in patient with breast cancer on adjuvant chemotherapy. Oncol Nurs Forum 1989; 16: 683-689
26. Pinto BM, Clark MM, Maruyama NC, Feder SI. Psychological and fitness changes associated with exercise participation among women with breast cancer. Psycho-Oncology 2003; 12: 118-126